Tamera D. Murphy

Tamera Murphy serves as a procurement specialist responsible for managing complex acquisitions in support of scientific and analytical instrumentation needs. Her role centers on executing full lifecycle contracting actions—from market research and solicitation development to award and contract administration—ensuring compliance with federal acquisition regulations and technical requirements. She plays a pivotal role in aligning procurement outcomes with mission-critical research and diagnostic objectives, frequently engaging with high-precision manufacturing and laboratory technology vendors to secure advanced equipment and specialized services. Murphy maintains a broad network of suppliers across the analytical instrumentation and diagnostic manufacturing sectors, partnering primarily with firms capable of delivering high-reliability, FDA-regulated, or ISO-certified products. While no single contractor dominates her portfolio, her contracting patterns reflect a preference for vendors with proven technical expertise in laboratory-grade equipment, in-vitro diagnostic systems, and precision calibration services. She consistently evaluates vendor capabilities through technical evaluations and past performance reviews, prioritizing quality, compliance, and innovation over cost alone. Her procurement strategy is overwhelmingly non-set-aside, with 98.4% of awards issued under full and open competition, reflecting a focus on technical merit and market capability rather than socioeconomic preferences. However, she maintains a measured commitment to small business participation, with 1.6% of awards directed toward Total Small Business Set-Asides under FAR 19.5, indicating selective but intentional inclusion of qualified small firms when market conditions permit. Murphy’s primary procurement focus lies in NAICS 334516 (Analytical Laboratory Instrument Manufacturing), which accounts for over half of her activity, underscoring deep expertise in procuring mass spectrometers, chromatography systems, and other laboratory analytics platforms. She also regularly acquires in-vitro diagnostic substances and related services under NAICS 325413, demonstrating specialized knowledge in clinical and research-grade diagnostic technologies. Her domain expertise extends to supporting scientific associations and technical publishing under NAICS 813910 and 511210, reflecting a broad but technically grounded approach to mission-enabling procurement.